Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Wahrmann

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Transplantation|August 19, 2004
Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohortMatthias Lorenz, Heinz Regele, Martin Schillinger, et al.
Trials|April 9, 2014
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trialFarsad Eskandary, Gregor Bond, Elisabeth Schwaiger, et al.
Transplantation|March 26, 2010
Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidatesMarkus Wahrmann, Michael Haidinger, Günther F Körmöczi, et al.
Plos One|April 9, 2019
CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activationMatthias Wieser, Teresa Francisci, Daniel Lackner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 2014
ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trialFarsad Eskandary, Markus Wahrmann, Peter Biesenbach, et al.
Human Immunology|October 18, 2012
Modified solid-phase alloantibody detection for improved crossmatch predictionMarkus Wahrmann, Gerald Hlavin, Gottfried Fischer, et al.
Transplantation|September 20, 2017
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 TrialJakob Mühlbacher, Bernd Jilma, Markus Wahrmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 14, 2012
Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipientsGregor Bartel, Markus Wahrmann, Elisabeth Schwaiger, et al.
Frontiers in Medicine|April 25, 2020
Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft RecipientsJakob Mühlbacher, Konstantin Doberer, Nicolas Kozakowski, et al.
Frontiers in Immunology|December 28, 2020
Methods to Detect MHC-Specific IgE in Mice and MenAnna Marianne Weijler, Jasmin Mucha, Andreas Michael Farkas, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Transplantation|August 19, 2004
Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohortMatthias Lorenz, Heinz Regele, Martin Schillinger, et al.
Trials|April 9, 2014
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trialFarsad Eskandary, Gregor Bond, Elisabeth Schwaiger, et al.
Transplantation|March 26, 2010
Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidatesMarkus Wahrmann, Michael Haidinger, Günther F Körmöczi, et al.
Plos One|April 9, 2019
CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activationMatthias Wieser, Teresa Francisci, Daniel Lackner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 2014
ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trialFarsad Eskandary, Markus Wahrmann, Peter Biesenbach, et al.
Human Immunology|October 18, 2012
Modified solid-phase alloantibody detection for improved crossmatch predictionMarkus Wahrmann, Gerald Hlavin, Gottfried Fischer, et al.
Transplantation|September 20, 2017
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 TrialJakob Mühlbacher, Bernd Jilma, Markus Wahrmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 14, 2012
Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipientsGregor Bartel, Markus Wahrmann, Elisabeth Schwaiger, et al.
Frontiers in Medicine|April 25, 2020
Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft RecipientsJakob Mühlbacher, Konstantin Doberer, Nicolas Kozakowski, et al.
Frontiers in Immunology|December 28, 2020
Methods to Detect MHC-Specific IgE in Mice and MenAnna Marianne Weijler, Jasmin Mucha, Andreas Michael Farkas, et al.
Pageof 7